Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.
about
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase I clinical trial of a no ...... patients with resected NSCLC.
@en
Phase I clinical trial of a no ...... patients with resected NSCLC.
@nl
type
label
Phase I clinical trial of a no ...... patients with resected NSCLC.
@en
Phase I clinical trial of a no ...... patients with resected NSCLC.
@nl
prefLabel
Phase I clinical trial of a no ...... patients with resected NSCLC.
@en
Phase I clinical trial of a no ...... patients with resected NSCLC.
@nl
P2093
P2860
P1433
P1476
Phase I clinical trial of a no ...... patients with resected NSCLC.
@en
P2093
Chunlei Ge
Haifeng Song
Jinyan Yang
Linfeng Song
Qinghua Tan
P2860
P2888
P356
10.1186/S12885-017-3859-3
P407
P577
2017-12-21T00:00:00Z
P6179
1099918797